title: MYD88 Mutations and Response to Ibrutinib in Waldenström's Macroglobulinemia.
authors.affiliation: Bing Center for Waldenström's Macroglobulinemia, Boston MA steven_treon@dfci.harvard.edu.
authors.forename: Steven P
authors.initials: SP
authors.lastname: Treon
authors.forename: Lian
authors.initials: L
authors.lastname: Xu
authors.forename: Zachary
authors.initials: Z
authors.lastname: Hunter
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D006801:Humans; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality
chemical_list: C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine